Pharmacology and Toxicology
Showing page 13 of 22 pages of list content
-
Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration into human lung cells
This article's authors -
Chemogenetic analysis of how receptors for short chain fatty acids regulate the gut-brain axis
This article's authors -
Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research
This article's authors -
Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-κB activation
This article's authors -
Tyrosine Kinase Inhibitor Family of Drugs as Prospective Targeted Therapy for COVID-19 Based on In Silico And 3D-Human Vascular Lung Model Studies
This article's authors -
In silicoandin vitroDemonstration of Homoharrintonine’s Antagonism of RBD-ACE2 Binding and its Anti-inflammatory and anti-thrombogenic Properties in a 3D human vascular lung model
This article's authors -
Mathematical Analysis and Topology of SARS-CoV-2, Bonding with Cells and Unbonding
This article's authors -
ProLungâ„¢-budesonideInhibits SARS-CoV-2 Replication and Reduces Lung Inflammation
This article's authors -
Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 In Vitro
This article's authors -
Discovery of Clioquinol and Analogues as Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, ACE2 and ACE2 - Spike Protein InteractionIn Vitro
This article's authors